Data support longer recurrenceāfree survival with nivolumab than with ipilimumab for stage III or IV melanoma
Women: Supporters or Supported?
Solid support
Supporting, Change of Support
HALOGENATED SUPPORTS AND SUPPORTED ACTIVATORS
Support for more-support